Roberto Galli was appointed Chief Financial Officer of Newron effective July 1st, 2023. He has been Vice President Finance of the Company since 2012. He has more than 20 years of experience in industry finance and auditing. He joined Newron in 2002. He has held several management positions within the Finance Department and has been involved in the Companyβs IPO, as well as M&A and other strategic corporate transactions: he was instrumental in finalizing the EIB funding facility. Before joining Newron, he was Senior Auditor & Business Advisor at PricewaterhouseCoopers (PwC), leading auditing projects in companies from the pharmaceutical, fashion, energy and automotive industries. He started his career as an auditor at Coopers&Lybrand. He holds a master degree in business economics from the University Luigi Bocconi in Milan and is registered with the national register of auditors. He is also a member of the Italian Angels for Biotech Association. Roberto Galli is Italian.
Image
/sites/newron-pharma-corp/files/about-us/picture%202024/Roberto-Galli5196.jpg
Position
CFO
Type
Don't show description
Off
Twitter link
Linkedin link